Particle.news

Download on the App Store

Bayer Considers Monsanto Bankruptcy as US Glyphosate Settlement Talks Advance

The company is pursuing a Missouri court settlement to resolve over 65,000 cancer lawsuits, with a Chapter 11 filing for Monsanto as a contingency plan.

Image
Image
Image
Image

Overview

  • Bayer aims to settle thousands of US glyphosate lawsuits in Missouri, where most cases are concentrated, while preparing for a possible Chapter 11 bankruptcy for Monsanto if talks fail.
  • The legal disputes stem from allegations that Monsanto's herbicide, Roundup, causes cancer, despite regulatory approvals deeming it safe in over 20 countries, including the US and EU.
  • Bayer has spent over €10 billion on settlements and legal costs since acquiring Monsanto in 2018, with more than 65,000 cases still unresolved.
  • The company has enlisted restructuring advisors from Latham & Watkins and AlixPartners to explore options, including bankruptcy protections under US law.
  • Heightened scrutiny from US Health Secretary Robert F. Kennedy Jr. and a pending Supreme Court decision on glyphosate warning labels add uncertainty to Bayer's legal and operational future.